Multiplex CRISPR/Cas9-Based Genome Editing for Correction of Dystrophin Mutations that Cause Duchenne Muscular Dystrophy

The CRISPR/Cas9 genome editing platform is a promising technology to correct the genetic basis of hereditary diseases. The versatility, efficiency, and multiplexing capabilities of the CRISPR/Cas9 system enable a variety of otherwise challenging gene correction strategies. Here we use the CRISPR/Cas...

Descripción completa

Detalles Bibliográficos
Autores principales: Ousterout, David G., Kabadi, Ami M., Thakore, Pratiksha I., Majoros, William H., Reddy, Timothy E., Gersbach, Charles A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2015
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4335351/
https://www.ncbi.nlm.nih.gov/pubmed/25692716
http://dx.doi.org/10.1038/ncomms7244

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4335351/
https://www.ncbi.nlm.nih.gov/pubmed/25692716
http://dx.doi.org/10.1038/ncomms7244

Ejemplares similares